Kfar Saba, Israel

Nili Beck

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Compugen Ltd. Corporation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nili Beck. Retrieved from https://idiyas.com/inventor/nili-beck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 338(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nili Beck: Innovator in Thrombospondin Research

Introduction

Nili Beck is a prominent inventor based in Kfar Saba, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of thrombospondin research. His work has led to advancements in understanding human thrombospondin 1 protein and its applications.

Latest Patents

Nili Beck holds a patent for a human thrombospondin polypeptide. This patent encompasses a human thrombospondin 1 protein, the polynucleotide encoding the protein, and a pharmaceutical composition thereof. This innovation has the potential to impact various therapeutic applications.

Career Highlights

Nili Beck is associated with Compugen Ltd., a biotechnology company that focuses on discovering and developing novel therapeutic drugs. His role at Compugen has allowed him to work on cutting-edge research and contribute to the advancement of medical science.

Collaborations

Nili Beck collaborates with talented individuals in his field, including Liat Mintz and Hanqing Xie. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

Nili Beck's contributions to thrombospondin research and his patent on human thrombospondin 1 protein highlight his role as an influential inventor in the biotechnology sector. His work continues to pave the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…